NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma
出版年份 2014 全文链接
标题
NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma
作者
关键词
-
出版物
MODERN PATHOLOGY
Volume 27, Issue 10, Pages 1331-1337
出版商
Springer Nature
发表日期
2014-03-07
DOI
10.1038/modpathol.2014.34
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
- (2013) S. Hu et al. BLOOD
- NIK Controls Classical and Alternative NF- B Activation and Is Necessary for the Survival of Human T-cell Lymphoma Cells
- (2013) L. Odqvist et al. CLINICAL CANCER RESEARCH
- Genetic heterogeneity of diffuse large B-cell lymphoma
- (2013) Jenny Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation
- (2012) Santiago Montes-Moreno et al. MODERN PATHOLOGY
- The biological and clinical impact of inhibition of NF-κB-initiated apoptosis in diffuse large B cell lymphoma (DLBCL)
- (2011) Prashant Bavi et al. JOURNAL OF PATHOLOGY
- Analysis of the coding genome of diffuse large B-cell lymphoma
- (2011) Laura Pasqualucci et al. NATURE GENETICS
- Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor- B-inducing kinase while activating both canonical and alternative nuclear factor- B pathways
- (2010) L. V. Pham et al. BLOOD
- Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
- (2010) B. Coiffier et al. BLOOD
- Oncogenically active MYD88 mutations in human lymphoma
- (2010) Vu N. Ngo et al. NATURE
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
- (2010) R. Eric Davis et al. NATURE
- Aggressive Lymphomas
- (2010) Georg Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation and Function of NF-κB Transcription Factors in the Immune System
- (2009) Sivakumar Vallabhapurapu et al. Annual Review of Immunology
- A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy
- (2009) W. W.L. Choi et al. CLINICAL CANCER RESEARCH
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
- (2009) Mara Compagno et al. NATURE
- Activation of the NF-κB signalling pathway in diffuse large B-cell lymphoma: clinical implications
- (2008) I Espinosa et al. HISTOPATHOLOGY
- Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma
- (2008) G. Lenz et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now